News and updatesCheck out what is going on

Article comes from https://www.prnewswire.com   SAN DIEGO, May 14, 2018 /PRNewswire/ — Immunicom, Inc., a medical technology company developing revolutionary non-pharmaceutical approaches for treating cancer and autoimmune diseases, has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its Immunopheresis™ therapy, which is based on a proprietary technology that selectively removes...

Polish Ministry of Health, Polish Development Fund and Patient Rights Commissioner have started a campaign to raise patients’ awareness of clinical trials called ‘Patient in Clinical Research’.   Clinical trials depend on the patients willingness to participate. When a patient is being informed by a doctor for the first time about clinical trial, there is...

Clinical trial is a situation in which specific group of people take a compound which can become a new medicine. There may also be a situation when a medical device is examined and it can be used to administer a drug or to monitor patients’ vital functions.   Clinical trials are a wide subjects on...

Currently, while submitting CTA, Sponsor has to attach signed agreements with all Investigators and sites. We all know how time-consuming it is to negotiate contracts and budget especially with big hospitals where the contacts goes from hands to hands to check it and find the most favorable conditions for either parties.   Polish legislator decided...

Regulation 536/2014 regarding the conduct of clinical trials will enter into force in 2019. It will be used directly in all European Union countries. Currently, there is a work under an act which is to regulate the areas that the EU legislator has left you to self-adapt and define for European countries.   However, the...

Rare diseases, affect only or as much as 6 – 8% of humanity. They are very rare, but nonetheless exist and people suffer because of them. Orphan drugs – because this is the name of medicinal products used in rare diseases must have an orphan designation by submitting an application for Authorities.   The most...

Rare diseases affect only or as much as 6 – 8% of humanity. They are very rare, but they do exist and people suffer from them.   In Poland disease is defined as a rare when for 10,000 people up to 5 of them become ill. If you take into account the number of people...

In 1923, Sir Frederick Grant Banting, a Canadian scholar at the age of 32, was awarded the Nobel Prize for the discovery of insulin, a hormone produced by beta-cells of the pancreas.   Diabetes is a metabolic disease during which insulin production is disturbed, the small amount of which causes hyperglycemia in the body because...

We celebrate the World Day for the Prevention of Obesity 24th October and that is why we would like to draw your attention to the overweight problem in Poland and its relationship to cancer.   Statistics In recent years, the number of people struggling with overweight and obesity increased significantly – in Poland this problem...

CRSN is a network of clinical research sites and is one of the largest alliances of clinical trial research sites in Poland. We specialize in coordinating clinical trials on sites level what gets our Partners access to a large sites network. We offer a convenient solutions which makes clinical trials management more efficient thanks to...